[Rimonabant helps in overweight patients with multiple cardiovascular risk factors such as type 2 diabetes]

Rev Med Suisse. 2008 Aug 27;4(168):1828.
[Article in French]
No abstract available

Publication types

  • Interview

MeSH terms

  • Cannabinoid Receptor Antagonists
  • Cardiovascular Diseases / prevention & control*
  • Diabetes Mellitus, Type 2 / complications
  • Diabetes Mellitus, Type 2 / drug therapy*
  • Humans
  • Hypoglycemic Agents / therapeutic use*
  • Overweight / complications*
  • Piperidines / therapeutic use*
  • Pyrazoles / therapeutic use*
  • Rimonabant

Substances

  • Cannabinoid Receptor Antagonists
  • Hypoglycemic Agents
  • Piperidines
  • Pyrazoles
  • Rimonabant